NCT03655535 - Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG

BTI320

Non-systemic galactomannan complex polysaccharide

OTHER

Placebo

Trial Locations (4)

Coastal Carolina Research Center, Mt. Pleasant

Advanced Research Institute, Ogden

Albuquerque Clinical Trials, Albuquerque

Coastal Metabolic Research Center, Inc., Ventura